Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 10, Number 3—March 2004
Research

Coronaviridae and SARS-associated Coronavirus Strain HSR1

Elisa Vicenzi*Comments to Author , Filippo Canducci*, Debora Pinna*, Nicasio Mancini*, Silvia Carletti*, Adriano Lazzarin*†, Claudio Bordignon*†, Guido Poli*†, and Massimo Clementi*†
Author affiliations: *San Raffaele Scientific Institute, Milan, Italy; †University “Vita-Salute” San Raffaele, Milan, Italy

Main Article

Figure 2

Effect of the sulfated polysaccharide heparin (100 μg/mL) added 30 minutes before injecting Vero cells with 100 PFU/mL of severe acute respiratory syndrome–associated coronavirus strain HSR1. The results are expressed as number of plaques/well and represent the mean ± SEM of two independent experiments each carried out in duplicate cultures. The p value was calculated by the Mann-Whitney U test.

Figure 2. Effect of the sulfated polysaccharide heparin (100 μg/mL) added 30 minutes before injecting Vero cells with 100 PFU/mL of severe acute respiratory syndrome–associated coronavirus strain HSR1. The results are expressed as number of plaques/well and represent the mean ± SEM of two independent experiments each carried out in duplicate cultures. The p value was calculated by the Mann-Whitney U test.

Main Article

Page created: February 08, 2011
Page updated: February 08, 2011
Page reviewed: February 08, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external